Concepedia

Peter Savas

PS

Statistics

Publications

5

Citations

268

H-Index

5

Active since

2017

Affiliations

Peter MacCallum Cancer Centre(Current)

Peter Savas is an author at Peter MacCallum Cancer Centre specializing in oncology, cancer immunotherapy, and immunotherapy.

Publications per year

2017–2023

5

Publications

5

Intratumoral CD8+ T cells with a tissue-resident memory phenotype mediate local immunity and immune checkpoint responses in breast cancer

Balaji Virassamy, Franco Caramia, Peter Savas et al. · Cancer Cell · 2023 · 221 citations · Full text

Life Sciences, Immunology, Oncology +17

Novel Targeted Agents and Immunotherapy in Breast Cancer

Ingrid A. Mayer, Rebecca Dent, Tira J. Tan et al. · American Society of Clinical Oncology Educational Book · 2017 · 15 citations

Medicine, Medicinal Chemistry, Oncology +17

Abstract PS12-28: Phase 1b study evaluating a triplet combination of ipatasertib (IPAT), atezolizumab, and a taxane as first-line therapy for locally advanced/metastatic triple-negative breast cancer (TNBC)

Peter Schmid, Peter Savas, Enrique Espinosa et al. · Cancer Research · 2021 · 12 citations

Medicine, Oncology, Pharmacology +17

On-treatment changes in tumor-infiltrating lymphocytes (TIL) during neoadjuvant HER2 therapy (NAT) and clinical outcome.

Stephen J. Luen, Gaia Griguolo, Paolo Nucíforo et al. · Journal of Clinical Oncology · 2019 · 10 citations

Medicine, Immunology, Oncology +17

Abstract PD10-02: A randomised phase II trial of single fraction or multi-fraction SABR (stereotactic ablative body radiotherapy) with atezolizumab in patients with advanced triple negative breast cancer (AZTEC trial)

Steven David, Peter Savas, Shankar Siva et al. · Cancer Research · 2022 · 10 citations

Medicine, Oncology, Pharmacology +17

1–5 of 5